Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir.
about
Immunology of AAV-Mediated Gene Transfer in the EyeGanciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applicationsTransscleral sustained vasohibin-1 delivery by a novel device suppressed experimentally-induced choroidal neovascularizationAlternate serotype adenovector provides long-term therapeutic gene expression in the eye.An empty E1, E3, E4 adenovirus vector protects photoreceptors from light-induced degenerationRetinoblastoma: one world, one visionAdenovirus gene therapy for pediatric cancers: shall we gather at the liver?Adenovirus vectors targeting distinct cell types in the retina.A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration.Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapyEvaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE.Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.Ocular localization and transduction by adenoviral vectors are serotype-dependent and can be modified by inclusion of RGD fiber modificationsVector platforms for gene therapy of inherited retinopathies.Decay accelerating factor (CD55)-mediated attenuation of complement: therapeutic implications for age-related macular degeneration.Targeted expression of suicide gene by tissue-specific promoter and microRNA regulation for cancer gene therapyProdrugs for improving tumor targetability and efficiency.Gene therapy for ocular diseasesRepublished review: Gene therapy for ocular diseases.Challenging issues in pediatric oncologyThe liberation of CD44 intracellular domain modulates adenoviral vector transgene expression.Antiangiogenic and Neurogenic Activities of Sleeping Beauty-Mediated PEDF-Transfected RPE Cells In Vitro and In VivoA new vision of mesenchymal stromal cellsAAV-mediated gene transfer for retinal diseases.Rescue of sight by gene therapy - closer than it may appear.Progress and prospects: gene therapy clinical trials (part 1).Barriers for retinal gene therapy: separating fact from fiction.AAV-mediated local delivery of interferon-beta for the treatment of retinoblastoma in preclinical modelsAn analysis of retinal gene therapy clinical trials.Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development.Non-viral retinal gene therapy: a review.Viral vectors for targeting the canine retina: a review.Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review.Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review.Intravitreal injection of melphalan for intraocular retinoblastoma.Convergence of Human Genetics and Animal Studies: Gene Therapy for X-Linked Retinoschisis.Versican G1 domain enhances adenoviral-mediated transgene expression and can be modulated by inhibitors of the Janus kinase (JAK)/STAT and Src family kinase pathways.Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward.Therapeutic Options for Retinoblastoma.Adenovirus-mediated delivery of CD46 attenuates the alternative complement pathway on RPE: implications for age-related macular degeneration.
P2860
Q27023474-4C7CD60F-E1D0-4432-875C-CB12274AF82FQ27026675-EA054D44-3AC8-48E0-8925-E90030D5D808Q28487648-125B222B-C111-4EB8-8317-F47CE221F93DQ33397385-80AC2784-57B0-4067-9318-8536B884C0B3Q33574612-EA2C1D97-EEE9-4CFC-8214-D539FAC40CECQ33748639-FBBE42DB-E468-466D-BBA0-3B6971483D46Q33804100-7DC4294B-A032-4B6A-877C-6684ED9FC1E3Q33845053-30F9BF7E-BFD0-45C9-8C06-CAC092398165Q33892696-D392A638-7215-46E9-8F68-9F43D356008FQ33992484-3CB983E5-129F-42D5-AFEB-8EB23E5A6546Q34069606-20869E9F-F83D-4DFF-92C2-426047626B71Q34208293-CE20C7B6-2614-44FA-A919-BFC6073DF8DAQ34215308-BD39F42E-49BD-4470-9B00-68CAF49F7871Q34561531-5ADDD007-CED3-4EE6-9D92-241856AB76E8Q34662323-6BF143E9-E299-4444-8CF6-73407B1F9749Q35082459-93F4F6E9-47B8-437D-801B-B76BC1E52E5CQ35095165-2654ADB4-C1B7-4C88-AE2B-F6CED00083E5Q35160142-D49CD5C4-9CF8-4EF2-A36D-BF56C6A0AB80Q35210756-ED4FDBD3-8E02-437D-8CB7-C3A10D049828Q35602419-28851440-65EA-461D-9DE1-86F55B3EEC08Q36294870-48C64F4F-2829-4ABA-8D4B-5007B9D69605Q36369034-9E5225F0-EB2A-4397-8D6B-C6FEBDC5F51AQ36401101-D6730484-DD08-4FA7-A808-7B38F6A38E5DQ36708300-519E30C0-9BD8-4831-8069-E061C137F8F7Q36951825-09B87A69-99C1-465F-AB5E-3DEFC731628EQ36957474-C700CB07-6DEC-47D7-8544-769EF86800BAQ37195446-B1D6EE7B-0786-488E-B121-C30CAB1DBDA7Q37301637-6BE61C45-546D-498A-998B-43767D53FB1CQ37608996-8CD29097-E0FB-4DEA-9813-547D35AB682CQ37861631-C72F95BF-4BBB-499C-8A7B-A490D1B4CB29Q37899932-C13D2EE6-023A-4799-A41F-632FD1FE9770Q38033669-4B2CEB91-171C-4A26-AA4B-F9649B8DC4AAQ38112406-3DCE7E34-DB6F-4790-87C7-6B3A1CF52F33Q38159603-C4FE23BD-7882-4786-BA20-4334A091BECFQ38390691-13E45B58-E4A7-462A-A79D-D622F00EE2BBQ38535037-FAB8669B-2479-44CF-9CF5-6779AB7A38EDQ38690392-E4620284-83AB-4F2B-91C4-615A6A28B523Q38732888-AA1310F2-B8B2-47F9-8222-31FA11191724Q38842907-7C7865E4-8643-4BE4-B475-980ACDD73AFBQ39595102-63C7D3FA-68EB-45AD-8659-E5FF79FD682F
P2860
Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Response of retinoblastoma wit ...... inase followed by ganciclovir.
@ast
Response of retinoblastoma wit ...... inase followed by ganciclovir.
@en
Response of retinoblastoma wit ...... inase followed by ganciclovir.
@nl
type
label
Response of retinoblastoma wit ...... inase followed by ganciclovir.
@ast
Response of retinoblastoma wit ...... inase followed by ganciclovir.
@en
Response of retinoblastoma wit ...... inase followed by ganciclovir.
@nl
prefLabel
Response of retinoblastoma wit ...... inase followed by ganciclovir.
@ast
Response of retinoblastoma wit ...... inase followed by ganciclovir.
@en
Response of retinoblastoma wit ...... inase followed by ganciclovir.
@nl
P2093
P356
P1476
Response of retinoblastoma wit ...... inase followed by ganciclovir.
@en
P2093
Claudia Kozinetz
Evelyn Paysse
Mary Y Hurwitz
Milton Boniuk
Murali Chintagumpala
Patricia Chévez-Barrios
Richard L Hurwitz
William Mieler
P304
P356
10.1200/JCO.2004.00.1883
P407
P577
2005-11-01T00:00:00Z